2985, cedar Brook drive

Decatur GA 30033

Global Hereditary Angioedema Drug Market 2020 and Forecast 2029

Global Hereditary Angioedema Drug Market 2020 and Forecast 2029

Published Date : 01-June-2020 | Pages : 200+ | Included Covid – 19 Impacted Analysis

Description

We, at CRR, have always studied the market in-depth and have been doing the pressure testing since our inception. Given the current pandemic situation, we all are of consensus that it is a constant now. Owing to which, the report addresses COVID-19 effects on this market too.

Key Companies :
Pharming Group NV
Shire plc
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals
Inc.
Ionis Pharmaceuticals
Inc.

Market by Type :
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist

Market by Application :
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

By Region :
Asia-Pacific: China, Southeast Asia, India, Japan, Korea, Oceania
Europe : Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland
North America : United States, Canada, Mexico
Middle East & Africa : GCC, North Africa, South Africa
South America : Brazil, Argentina, Columbia, Chile, Peru

In this study, the years considered to estimate the market size of report are as follows:
History Year: 2013-2018
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2029
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Additional information

Select License

,

TOC

Chapter 1 Global Hereditary Angioedema Drug Market Overview
1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Hereditary Angioedema Drug Market
1.4 Restraints for Hereditary Angioedema Drug Market
1.5 Opportunities for Hereditary Angioedema Drug Market
1.6 Trends for Hereditary Angioedema Drug Market
1.7 COVID-19 Impact Assessment on Hereditary Angioedema Drug Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Hereditary Angioedema Drug Market Overview
2.1 Global Hereditary Angioedema Drug Market by Product Type
2.1.1 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Hereditary Angioedema Drug Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Hereditary Angioedema Drug Market by End User
2.2.1 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Hereditary Angioedema Drug Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Hereditary Angioedema Drug Market by Region
2.3.1 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Hereditary Angioedema Drug Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Hereditary Angioedema Drug Market Outlook (2013-2029)
2.4.1 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Hereditary Angioedema Drug Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Hereditary Angioedema Drug Market Y-o-Y Growth Rate by Region
2.8.2 Global Hereditary Angioedema Drug Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Hereditary Angioedema Drug Market Y-o-Y Growth Rate by End User
2.9 Global Hereditary Angioedema Drug Market Share Comparison (2013-2029)
2.9.1 Global Hereditary Angioedema Drug Market Share by Region
2.9.2 Global Hereditary Angioedema Drug Market Share by Product Type
2.9.3 Global Hereditary Angioedema Drug Market Share by End User

Chapter 3 North America Hereditary Angioedema Drug Market Overview
3.1 North America Hereditary Angioedema Drug Market by Product Type
3.1.1 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Hereditary Angioedema Drug Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Hereditary Angioedema Drug Market by End User
3.2.1 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Hereditary Angioedema Drug Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Hereditary Angioedema Drug Market by Region
3.3.1 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Hereditary Angioedema Drug Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Hereditary Angioedema Drug Market Outlook (2013-2029)
3.4.1 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Hereditary Angioedema Drug Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Hereditary Angioedema Drug Market Y-o-Y Growth Rate by Region
3.8.2 North America Hereditary Angioedema Drug Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Hereditary Angioedema Drug Market Y-o-Y Growth Rate by End User
3.9 North America Hereditary Angioedema Drug Market Share Comparison (2013-2029)
3.9.1 North America Hereditary Angioedema Drug Market Share by Region
3.9.2 North America Hereditary Angioedema Drug Market Share by Product Type
3.9.3 North America Hereditary Angioedema Drug Market Share by End User

Chapter 4 Europe Hereditary Angioedema Drug Market Overview
4.1 Europe Hereditary Angioedema Drug Market by Product Type
4.1.1 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Hereditary Angioedema Drug Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Hereditary Angioedema Drug Market by End User
4.2.1 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Hereditary Angioedema Drug Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Hereditary Angioedema Drug Market by Region
4.3.1 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Hereditary Angioedema Drug Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Hereditary Angioedema Drug Market Outlook (2013-2029)
4.4.1 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Hereditary Angioedema Drug Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Hereditary Angioedema Drug Market Y-o-Y Growth Rate by Region
4.8.2 Europe Hereditary Angioedema Drug Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Hereditary Angioedema Drug Market Y-o-Y Growth Rate by End User
4.9 Europe Hereditary Angioedema Drug Market Share Comparison (2013-2029)
4.9.1 Europe Hereditary Angioedema Drug Market Share by Region
4.9.2 Europe Hereditary Angioedema Drug Market Share by Product Type
4.9.3 Europe Hereditary Angioedema Drug Market Share by End User

Chapter 5 Asia Pacific Hereditary Angioedema Drug Market Overview
5.1 Asia Pacific Hereditary Angioedema Drug Market by Product Type
5.1.1 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Hereditary Angioedema Drug Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Hereditary Angioedema Drug Market by End User
5.2.1 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Hereditary Angioedema Drug Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Hereditary Angioedema Drug Market by Region
5.3.1 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Hereditary Angioedema Drug Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Hereditary Angioedema Drug Market Outlook (2013-2029)
5.4.1 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Hereditary Angioedema Drug Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Hereditary Angioedema Drug Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Hereditary Angioedema Drug Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Hereditary Angioedema Drug Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Hereditary Angioedema Drug Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Hereditary Angioedema Drug Market Share by Region
5.9.2 Asia Pacific Hereditary Angioedema Drug Market Share by Product Type
5.9.3 Asia Pacific Hereditary Angioedema Drug Market Share by End User

Chapter 6 South America Hereditary Angioedema Drug Market Overview
6.1 South America Hereditary Angioedema Drug Market by Product Type
6.1.1 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Hereditary Angioedema Drug Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Hereditary Angioedema Drug Market by End User
6.2.1 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Hereditary Angioedema Drug Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Hereditary Angioedema Drug Market by Region
6.3.1 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Hereditary Angioedema Drug Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Hereditary Angioedema Drug Market Outlook (2013-2029)
6.4.1 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Hereditary Angioedema Drug Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Hereditary Angioedema Drug Market Y-o-Y Growth Rate by Region
6.8.2 South America Hereditary Angioedema Drug Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Hereditary Angioedema Drug Market Y-o-Y Growth Rate by End User
6.9 South America Hereditary Angioedema Drug Market Share Comparison 2013-2029
6.9.1 South America Hereditary Angioedema Drug Market Share by Region
6.9.2 South America Hereditary Angioedema Drug Market Share by Product Type
6.9.3 South America Hereditary Angioedema Drug Market Share by End User

Chapter 7 MEA Hereditary Angioedema Drug Market Overview
7.1 MEA Hereditary Angioedema Drug Market by Product Type
7.1.1 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Hereditary Angioedema Drug Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Hereditary Angioedema Drug Market by End User
7.2.1 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Hereditary Angioedema Drug Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Hereditary Angioedema Drug Market by Region
7.3.1 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Hereditary Angioedema Drug Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Hereditary Angioedema Drug Market Outlook (2013-2029)
7.4.1 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Hereditary Angioedema Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Hereditary Angioedema Drug Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Hereditary Angioedema Drug Market Y-o-Y Growth Rate by Region
7.8.2 MEA Hereditary Angioedema Drug Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Hereditary Angioedema Drug Market Y-o-Y Growth Rate by End User
7.9 MEA Hereditary Angioedema Drug Market Share Comparison (2013-2029)
7.9.1 MEA Hereditary Angioedema Drug Market Share by Region
7.9.2 MEA Hereditary Angioedema Drug Market Share by Product Type
7.9.3 MEA Hereditary Angioedema Drug Market Share by End User

Chapter 8 Global Hereditary Angioedema Drug Market Company Profiles
8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis…
Pharming Group NV
Shire plc
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals
Inc.
Ionis Pharmaceuticals
Inc.

Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

$ 3900$ 7800

  • Corporate Price
  • Individual Price
Clear

For More Information

Email us at:

sales@credenceresearchreports.com

Call us at:

+1-925-478-7203